Valantine Hannah
Pacific Biosciences of California, Inc. · Director
Valantine Hannah is listed in filings as Director at Pacific Biosciences of California, Inc.. This profile follows SEC Form 4 activity through Jun 4, 2026, including sale activity. Recent filings connect the profile to Pacific Biosciences of California, Inc. (PACB), BridgeBio Pharma, Inc. - Common Stock (BBIO), and CareDx, Inc. (CDNA). The current snapshot covers public activity from Jun 18, 2024 to Jun 4, 2026. Reported amounts are shown as $353.1K to $237.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $978k14.6k shares | SellFeb 27, 2026 | $67.08 | $81.46 | |
| $739k10.9k shares | SellFeb 27, 2026 | $67.84 | $81.46 | |
| $2M25.5k shares | SellNov 12, 2025 | $66.07 | $81.46 | |
| $83k1.9k shares | SellJun 26, 2025 | $44.03 | $81.46 | |
| $68k1.5k shares | SellJun 26, 2025 | $44.01 | $81.46 | |
| $39k876 shares | SellJun 26, 2025 | $44.11 | $81.46 | |
| $18k398 shares | SellJun 26, 2025 | $44.13 | $81.46 | |
| $203k10.6k shares | SellJun 18, 2025 | $19.16 | $40.34 | |
| $172k4.3k shares | SellJun 10, 2025 | $40.00 | $81.46 |